Casper Sleep Inc. Balance Sheet

Ask AI

Financial Statements

In millions of USD, except per-share amounts

	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020	Q1 FY2020 As of Mar 31, 2020
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Accounts receivable, net
Prepaid expenses and other current assets
Inventory, net
Total current assets
Property and equipment, net
Other assets
Total assets
Liabilities and Stockholders’ (Deficit) / Equity
Current liabilities:
Accounts payable
Accrued expenses
Deferred revenue
Short-term debt
Other current liabilities
Total current liabilities
Long-term debt
Other liabilities
Total liabilities
Convertible preferred stock, $0.000001 par value - zero and 19,213 shares authorized; zero and 19,181 issued and outstanding as of December 31, 2020 and December 31, 2019, respectively
Stockholders’ (deficit) / equity:
Common stock, $0.000001 par value - 170,000 and 170,000 shares authorized; 41,492 and 40,539 issued and outstanding as of September 30, 2021 and December 31, 2020, respectively
Class A common stock
Class B common stock
Total common stock, $0.000001 par value - 170,000 and 170,000 shares authorized; 41,492 and 40,539 issued and outstanding as of September 30, 2021 and December 31, 2020, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total stockholders’ (deficit)/equity
Total liabilities and stockholders’ (deficit) / equity

Comments